Capítulo 1.2. Shock

Bibliografía

 
  1. Darovic GO, Rokowsky JS. Shock. En: Patrick ML, Woods SL, Craven RF, et al., eds. Medical-Surgical Nursing. Pathophysiological Concepts. Philadelphia: JB Lippincott, 1991; 123-142. 
  2. Komatsu T, Shibutani K, Okamoto K, Kumar V, Kubal K, Sanchala V et al. Critical level of oxygen delivery after cardiopulmonary bypass. Crit Care Med 1987; 15:194-197.
  3. Shibutani K, Komatsu T, Kubal K, Sanchala V, Kumar V and Biizarri DV. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11:640-643.
  4. Siegel JH, Greenspan M, Del Guercio LR. Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg 1967; 165:504-517.
  5. Shoemaker WC. Cardiorespiratory patterns in complicated and uncomplicated septic shock. Ann Surg 1971; 174:119-125.
  6. Duff JH, Groves AC, McLean AP, LaPointe R, MacLean LD. Defective oxygen consumption in septic shock. Surg Gynecol Obstet 1969; 128:1051-1060.
  7. Jacobson D and Singer M. The cell, the mitochondrion, oxygen and sepsis. En: Vincent JL (eds). Yearbook of Intensive Care and Emergency Medicine., Heidelberg: Springer-Verlag 1996; 263-274.
  8. Mann T, Goldberg S, Mudge GH and Grossman W. Factors contributing to altered left ventricular diastolic properties during angina pectoris. Circulation 1979; 59:14-20.
  9. Lorell BH, Wexler LF, Momomura SI, Weinberg E and Apstein CS. The influence of pressure overload left ventricular hypertrofhy on diastolic properties during hypoxia in isovolumically contracting rat hearts. Circ Res 1986; 58 :653-663.
  10. Hemmer M. Regional blood flow and hemorrhage. How long de the protective mechanisms go?. Intensive Care Med 1996 22:1006-1008
  11. Wahl M and Schilling L. Regulation of cerebral blood flow: a brief review. En Untenberg AW, Schneider GH and Lanksch WR, eds. Monitoring of cerebral blood flow and metabolisme in intensive care. Wien New York: Springer, 1993; 48-61.
  12. Kuschinsky W Coupling of function, metabolism and blood flow in the brain. News Physiol Sci 1987; 2:217-223. 
  13. Pouleur H, Covell JW and Ross J J : Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure. Circulation 1980; 61:328-337.
  14. Glantz SA, Misbach GA, Moores WY, Mathey DG, Lakven J, Stone DF, et al. The pericardium substantially affects the left ventricular diastolic pressure volume relationship in the dog. Cir Res 1978; 42:433-441.
  15. Braunwald E and Frahm CJ. Studies on Starling¨s law of the heart.IV. Observations on hemodynamic functions of left atrium in man. Circulation 1961; 24:633-640.
  16. Thompson JA, Millen JE, Glauser FL and Hess ML. Role of 5-HT2 receptor inhibition in pulmonary embolization. Circ Shock 1986; 20:299-309.
  17. Utsonomiya T, Krausz MM, Levine L, Sepro D and Hectman HB. Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest 1982; 70:361-368.
  18. Horgan MJ, Fenton JW and Malik AB. Alpha-thrombin-induced pulmonary vasoconstriction. J Appl Physiol 1987; 63:1993-2000.
  19. Chien S. Role of the sympathetic nervous system in hemorrhage. Physiol Rev 1967; 47:214-288.
  20. Poter JM, Sussman MS and Bulkley GB. Splanchinc vasospasm in circulatory shock. En Marston A, Bulkley GB and Fiddian-Green RG, eds. Spanchinc Ischemia and Multiple Organ Failure. London: Edward Arnold, 1989; 175-187. 
  21. Reilly PM, MacGowan S, Miyachi M, Shiller HJ Vickers S et al. Mesenteric vasoconstriction in cardiogenic shock in pigs. Gastroenterol 1992; 102:1968-1979. 
  22. Liard JF : Vasopressin in cardiovascular control : Role of circulating vasopressin. Clin Sci 1984; 67:473-481.
  23. Bond RF, Bond CH, Peissner LC and Manning ES. Prostaglandin modulation of adrenergic vascular control during hemorrhagic shock. Am J Physiol 1981; 241:H85-90.
  24. Vargish T and Beamer K .Hemodynamic effects of naloxone in early canine hypovolemic shock. Circ Shock 1985; 17:45-57.
  25. Evans SF, Medbak S, Hinds CJ, Tomlim SJ, Varley JG and Rees LH . Plasma levels in biochemical characterizations of circulatory met-enkephalin in canine endotoxin shock. Life Sci 1984; 34:1481-1486.
  26. Shatney CH, Cohen RM, Cohen MR and Imagawa DK. Endogenous opioid activity in clinical hemorragic shock. Surg Gynecol Obstet 1985; 160:547-551.
  27. Pasi A, Moccetti T, Legler M, Mueller J Foletta D et al. Elevation of blood levels of beta-endorphin-like inmunoreactivity in patients with shock. Res Commun Chem Pathol Pharmacol 1983; 42:509-512.
  28. Thiemermann C, Szabo C, Mitchell JA and Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 1993; 90:267-271.
  29. Hift H and Campos HA. Changes in the subcellular distribution of cardiac catecholamines in dogs dying in irreversible hemorrhagic shock. Nature 1962; 196:678-688. 
  30. Coleman B and Glaviano VV. Tissue levels of norepinephrine in hemorrhagic shock. Science 1962; 139:54-63.
  31. Hinshaw LB, Jordan MM and Vick JA. Histamine release and endotoxin shock in the primate. J Clin Invest 1961; 40:1631-1640. 
  32. Nagy S, Nagy A, Adamicza A, Szabo I, Tarnoky K et al. Histamine level changes in the plasma and tissues in hemorrhagic shock. Circ Shock 1986; 18:227-239.
  33. O´Donnell TF, Clowes GHA, Talamo RC, Colman RW. Kinin activation in the blood of patientes with sepsis. Surg Gynecol Obstet 1976; 143:539-545.
  34. Lefer AM. Significance of lipid mediators in shock states. Circ -Shock 1989; 27:3-12.
  35. Ayala A, Wang P, Ba ZF, Ertel W and Chanding IH. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage . Am J Physiol 1991; 260:R167-171.
  36. Abraham E, Richmond NJ and Chang YH. Effects of hemorrhage on interleukin-1 production. Circ Shock 1988; 25:33-40.
  37. Pellicane JV, DeMaria EJ, Abd-Elfattah A, Reines HD, Vannice JL and Carson KW. Interleukin-1 receptor antagonist improves survival and preserves organ adenosine-5´triphosphate after hemorrhagic shock. Surgery 1993; 114:278-283. 
  38. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P and Shoemaker WC. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845.
  39. Tan Lr, Waxman K, Scannell G, Ioli G and Granger GA. Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 1993; 34:634-638. 
  40. Williams TJ and Hellewell. Endothelial cell biology : Adhesion molecules involved in the microvascular inflammatory response. Am Rev Respir Dis 1992; 146:S45- 50.
  41. Ruoslahti E. Integrins. J Clin Invest 1991; 87:1-5.
  42. Barroso-Aranda J, Schmid-Schonbein GW, Zweifach BW and Engler RL. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 1988; 63:437-447.
  43. Hurd TC, Dasmahapatra KS, Rush BF Jr and Madriedo JW. Red blood cell deformability in human and experimental sepsis. Arch Surg 1988; 123:217-220. 
  44. Powell RJ, Machiedo GW and Rush BF Jr. Decreased red blood cell deformability and impaired oxygen utilization during human sepsis. Am Surg 1993; 59:65-68.
  45. Lefer AM. Properties of cardioinhibitory factors produced in shock. Fed Proc 1978; 37:2734-2740.
  46. Lundgren O, Haglund U, Isaksson O and Abe T. Effects on myocardial contractility of blood-borne material released from the feline small intestine in simulated shock. Circ Res 1976; 38 :307-315.
  47. Horton JW and White DJ. Lipid peroxidation contributes to cardiac deficits after ischemia and reperfusion of the small bowel. Am J Physiol 1993; 264 :H1686-1692.
  48. De Fily DV and Chilian WM. Coronary microcirculation : autoregulation and metabolic control. Basic Res Cardiol 1995; 90:112-118. 
  49. Lefer AM. Interaction between myocardial depressante factor and vasoactive mediators with ischemia and shock. Am J Physiol 1987; 252:R193-205. 
  50. Parrillo JE, Burch C, Shelhamer JH, Parker MH, Natanson C and Schuette W. A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539-53.
  51. Firth GB and Lange RA. Pathophysiology and management of primary pump failure. En Gersch BJ, Rahimtoola SH, eds. Acute myocardial infarction. Nueva York : Elsevier, 1990; 218-235.
  52. Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978; 93:527-617.
  53. Hack CE and Thijs LG. The orchestra of mediators in the pathogenesis of septic shock: a review. En: Vincent JL (eds) Update 1991. Update in Intensive care and Emergency Medicine. Heidelberg: Springer-Verlag, 1991; 90-96.
  54. Porembka DT. Cardiovascular abnormalities in sepsis. New Horizons 1993; 2:324-341.
  55. Parrillo JE. Cardiovascular dysfunction in septic shock: new insights into a deadly disease. Intern J Cardiol 1985; 7:314-321.
  56. Groeneveld AB, Bronsveld W, Thijs LG. Hemodynamic determinants of mortality in human septic shock. Surgery 1986; 99:140-152.
  57. Groeneveld AB, Nauta JJP, Thijs LG. Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med 1988; 14:141-147.
  58. Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW et al. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hipotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA. 1990; 87:3629-32.
  59. Lowenstein ChJ, Dinerman JL and Snyder SH. Nitric Oxide: A Physiologic Messenger. Ann Intern Med 1994; 120:227-237.
  60. Monsalve F, Rucabado L, Salvador A, Bonastre J, Cuñat J and Ruano M. Myocardial depresion in septic shock caused by meningococcal infection. Critical Care Med; 1984; 2:1021-1023.
  61. Parker MM, Shelhamer JH, Bacharach SM, Green MV, Natanson C et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490.
  62. Cain SM. Supply dependency of oxygen uptake in ARDS: myth or reality ? Am J Med Sci 288:119-124.
  63. Whitworth PW, Cryer HM, Garrison RN, Baumgasten TE and Harris PD. Hypoperfusion of the intestinal microcirculation without decreased cardiac output during live Escherichia coli sepsis in rats. Cir Shock 1989; 27:111-122.
  64. Ellman H. Capillary permeability in septic patients. Crit Care Med 1984; 12:629-633.
  65. Ellsworth ML, Goldfarb RD, Alexander RS, Bell DR and Powers SR. Microembolization induced oxygen utilisation impairment in the canine gracilis muscle. Adv Shock Res 1981; 5:89-99. 
  66. Tremper KK. Pulse oximetry. Chest 1989; 94:713-715.
  67. Gutierrez G and cabezas RA. Regional monitoring of gut mucosa viability. En: Pinsky MR, Dhainaut JF and Artigas A. (Eds.) The Splanchnic circulation: No longer a silent partner. Berlin: Springer-Verlag, 1995; 100-112.
  68. Calvet X, Baigorri F and Artigas A. gastric intramucosal ph determination: Limitations of the technique. En: Pinsky MR, Dhainaut JF and Artigas A. (Eds.) The Splanchnic circulation: No longer a silent partner. Berlin: Springer-Verlag, 1995; 113-127.
  69. Grassino A, Macklem PT : Respiratory muscle fatigue and ventilatory failure. Ann Rev Med. 1984; 35:625-647.
  70. Hall JB, Wood LD. Liberation of the patient from mechanical ventilation. JAMA 1987; 257:1621-1628.
  71. Armaganidis A, Kotanidon A, Roussos C. Mechanical ventilation in circulatory failure. En: Vincent JL (eds). Yearbook of Intensive Care and Emergency Medicine. Berlin-Heidelberg: Springer-Verlag, 1995; 185-208.
  72. Moss GS, Proctor HJ, Homer LD and Herman CH. A comparison of asanguineous fluids and whole blood in the treatment of haemorrhagic shock. Surgery 1969; 129:1247-1257.
  73. Vincent JL. Fluids for resuscitation. Br J Anaesth 1991; 67:185-193.
  74. Bisonni RS, Holtgrave DR, Lawler F and Marley DS. Colloid versus crystalloids in fluid resuscitation: An analysis of randomised contolled trials. J Fam Pract 1991; 32:387-390.
  75. Velasco IT, Rocha e Silva M, Oliveira MA and Silva RI. Hypertonic and hyperoncotic resuscitation from severe haemorrhagic shock in dogs. A comparative study. Crit Care Med 1989; 17:261-264.
  76. Holcroft JW, Vasser MJ, Turner JE, Derlet RW and Cramer GC. 3% NaCl and 7,5% NaCl/Dextran 70 in the resuscitation of severely injured patients. Ann Surg 1987; 206:279-288.
  77. Lynn WA, Cohen J. Management of septic shock. J Infect 1995; 30:207-212.
  78. Packman MI, Rackow E. Optimun left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983; 11:165-169.
  79. Marik PE, Mohedin M. The contrasting effect of dopamine and norepinephrine on systemic and splachnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354-1357.
  80. Martin C, Papazian L, Perrin G, Saux P and Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock ?. Chest 1993; 103:1826-1831.
  81. Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: Low dose dopamine or low dose dobutamine?. Crit Care Med 1994; 22:1919-1925.
  82. Shoemaker WC, Appel PL, Kram HB, Waxman K and Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest 1988; 1176-1186.
  83. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds GC and Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722.
  84. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032.
  85. Hinds C, Watson D. Manipulating hemodynamics and oxygen transport in critically ill patients [editorial] N Engl J Med 1995; 333:1074-1075.
  86. Weikert LF, Bernard GR. Pharmacotherapy of sepsis. Clin Chest Med 1996; 17:289-305.
  87. Ralston DR, St John RC. Immunotherapy for sepsis. Clin Chest Med 1996; 17:307-317.
  88. Rush BF. Irreversibility in post-transfusion phase of haemorrhagic shock. Adv Exp Med Biol 1971; 23:215-234.
  89. Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, et al. Fluid resuscitation in circulatory shock. A comparison of the cardiorespiratory effect of albumin, hetarstach and saline solutions in patients with hipovolemic shock. Crit Care Med 1983; 11:839-850.
  90. American College of Surgeons, Commitee on Trauma: Advanced Trauma Life Support Course, Student Manual, Chicago. 1992.
  91. Bickell WH, Bruttig SP, Millnamow GA, O´Bernar J and Wade CE. The detrimental effects of intravenous crystalloid after aortotomy in swine. Surgery 1991; 110:529-536.
  92. Kaweski SM, Sise MJ, Virgilio RW. The effects of prehospital fluids on survival in trauma patients. J Trauma 1990; 30:1215-1218.
  93. Krausz MM, Bar-Ziv M, Rabinovic R and Gross D. "Scoop and Run" or stabilize haemorrhagic shock with normal saline or small volume hypertonic saline. J Trauma 1992; 33:6-10.
  94. Shaftan GW, Chiu C, Dennis C and Harris B. Fundamentals of physiologic control of arterial hemorrhage. Surgery 1965; 58: 851-856.
  95. Bickell WH, Wall-MJ Jr, Pepe PE, Martin RR, Ginger VF, et al. Immediate versus delayed fluid resuscitation for hipotensive patients with penetrating torso injuries. N Engl J Med 1994; 331 1105-1109.
  96. Martin RR, Bickell WH, Pepe PE, Burch JM and Mattox KL. Prospective evaluation of preoperative fluid resuscitation in hipotensive patients with penetrating truncal injury: A preliminary report. J Trauma 1992; 33:354-361.
  97. Chadwick S , Edwards JD, Nightingale DN. The adequacy of volume replacement prior to admission to ICU. Crit Care Med 1993; 21:S246(Abst).
  98. Scalea TM, Hartnett RW, Duncan AO, Atweh NA, Phillips TF, et al. Central venous oxygen saturation: A Useful clinical tool in trauma patients. J Trauma 1990; 30:1539-1543.
  99. Scalea TM, Holman M, Fuortes M, Baron BJ, Phillips TF, et al. Central venous blood oxygen saturation: An early accurate measurement of volume during hemorrhage. J Trauma 1988; 28:725-732.
  100. Cercek B, Shah PK. Complicated acute myocardial infarction: Heart failure, shock, mechanical complications. Cardiol Clin 1991; 9:569-593.
  101. Bigger JT, Fleiss JL, Kleiger R, Miller JP and Rolnitzky LM. The relationship among ventricular arrhytmias, left ventricular dysfunction and mortality in the two years after myocardial infarction. Circulation 1984; 69:250-258.
  102. DeWood HA, Notske RN, Hensley GR, Shields JP and O´Grady WB. Intra-aortic balloon counterpulsation with and without reperfusion of myocardial infarction shock. Circulation 1980; 61:1105-1112.
  103. Hibbard MD, Holmes DR, Bailey KR, Reeder GS and Bresnahan JF: Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992; 19:639-646.
  104. Heuser RR, Mattdox GL, Goss GE. Coronary angioplasty in the treatment of cardiogenic shock: The therapy of choice. J AM Coll Cardiol 1986; 7:219A.
  105. O'Neill WW, Erbel R, Laufer N. Coronary angioplasty therapy for cardiogenic shock complicating acute myocardial infarction. Circulation 1985; 72(suppl).III-309.